GDR: Rapid pharmacogenetic testing adoption accelerates, with national and international scale in sight

Rapid pharmacogenetic testing solutions are driving revenue growth and adoption in UK and international markets, with two CE-IVD certified products addressing critical needs in neonatal and stroke care. National adoption is expected to accelerate post-2027 with NICE guidance and NHS procurement, wh…